claim
Harmala alkaloids act as monoamine oxidase inhibitors (MAOIs) and influence serotonin signaling similarly to selective serotonin reuptake inhibitors (SSRIs), allowing for dynamic regulation of BDNF levels.
Authors
Sources
- Effects of psychedelics on neurogenesis and broader neuroplasticity link.springer.com via serper
Referenced by nodes (3)
- selective serotonin reuptake inhibitors concept
- harmala alkaloids concept
- monoamine oxidase inhibitors concept